• Agenda
    • Programs
    • Plenary Session
    • Interactive Discussions
    • Speaker Biographies
    • Attendees
    • 1-on-1 Networking
    • Archives
  • Sponsor/Exhibitor
    • Event Features & Attendee Demographics
    • Sponsorship Opportunities
    • Current Sponsors
    • Current Exhibitors/Floorplan
    • Exhibitor Prospectus
    • Exhibit Services/Schedule
    • Lead Generation Opportunities
    • FAQ
    • Sponsor & Exhibitor Portal
  • Downloads
    • Brochures
    • Podcasts
    • Speaker Interviews
    • Whitepapers
    • Articles
    • Videos
  • Travel
    • Travel Information
    • Health and Safety
  • Posters
    • Poster Information
    • Poster Titles
  • Get Involved
    • Ways to Participate
    • Media Partners
  • Register
    • Conference Pricing
    • Group Pricing
    • On-Demand Pricing
    • Request a Press Pass
Next Generation DX

Download Articles - Complimentary

IVDR Creating ‘Significant Challenges’ For Global Precision Medicine Trials

Promise Of Liquid Biopsies Coming To Light

Leading-Edge Approaches To Early Cancer Detection

Overcoming the ‘Diagnostic Dilemma’ With Point-of-Care Testing

Updated Definition of ‘Clinical Utility’ Could Foster Adoption of Genetic Testing

Community Pharmacies Have Become Public Health Destinations

Current Perspectives on the VALID Act

Debate Winners Make the Case Against Antigen Testing During Emerging Outbreaks

IVDR Creating ‘Significant Challenges’ For Global Precision Medicine Trials

DNA Methylation Making Its Mark In Early Cancer Detection

Navigating The Emergency Use Authorization Process for Diagnostics

At Dx Conference, FDA's Gutierrez Sheds Further Light on Plans for Risk-Based LDT Regulation


Outlook YouTube Facebook LinkedIn Twitter
#NGDx23

speaker proposal
Register Early For Maximum Savings
CAG
attendees

2023 Conference Programs

POCT and Infectious Disease Stream

Enabling Point-of-Care Diagnostics

Advanced Diagnostics for Infectious Disease

Companion DX Reimbursement Stream

Advancing Novel Frameworks for Companion Diagnostics

Coverage and Reimbursement for Advanced Diagnostics

Early Detection and Liquid Biopsy Stream

Liquid Biopsy for Disease Management

Early Cancer Surveillance

POTC Product Stream

Enabling Point-of-Care Diagnostics

Decentralized Point-of-Care Testing

CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Genomics

Healthcare

IT & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy